fluconazole has been researched along with galactose in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, J; Douglas, LJ; Faddoul, FF; Ghannoum, MA; Hoyer, LL; Leidich, SD; Mukherjee, PK | 1 |
| Gugel, A; Laverdiere, M; Leisenring, W; Marr, KA | 1 |
| An, MM; Cao, YB; Chen, HS; Gao, PH; Jia, XM; Jiang, YY; Sun, HH; Wang, Y; Xu, Z; Yan, L; Zhang, JD | 1 |
| Abrahamsen, TG; Gaustad, P; Warris, A; Winn, RM | 1 |
| Baden, LR; Boeckh, M; Bolaños-Meade, J; Brown, J; Carter, SL; Confer, DL; Dipersio, JF; Gersten, ID; Kurtzberg, J; Leather, HL; Marr, KA; Maziarz, RT; Mendizabal, AM; Small, TN; Stadtmauer, EA; Walsh, TJ; Wingard, JR | 1 |
| Kontoyiannis, DP | 1 |
| Berking, S; Doedens, D; Fiegl, M; Horns, H; Ostermann, H; Rieger, CT | 1 |
| Alam, MS; Alshahrani, MM; Hanee, U; Jeong, JE; Kim, B; Mahmud, S; Matin, MM; Matin, P; Rahman, MR | 1 |
| Dey, P; Kaity, S; Maiti, S; Maji, S; Ray, S; Sa, B | 1 |
| Borowicz, SM; Clemes Külkamp-Guerreiro, I; da Rosa Monte Machado, G; Domingues Bianchin, M; Meneghello Fuentefria, A; Pippi, B; Raffin Pohlmann, A; Stanisçuaski Guterres, S | 1 |
1 review(s) available for fluconazole and galactose
| Article | Year |
|---|---|
Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Mannans; Mycoses | 2011 |
2 trial(s) available for fluconazole and galactose
| Article | Year |
|---|---|
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Child; False Negative Reactions; Female; Fluconazole; Galactose; Humans; Immunoenzyme Techniques; Itraconazole; Male; Mannans; Middle Aged; Sensitivity and Specificity | 2005 |
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Disease-Free Survival; Double-Blind Method; Drug Monitoring; Fluconazole; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mannans; Middle Aged; Mycoses; Myeloablative Agonists; Survival Rate; Transplantation, Homologous; Young Adult | 2010 |
7 other study(ies) available for fluconazole and galactose
| Article | Year |
|---|---|
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.
Topics: Acrylic Resins; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Chlorhexidine; Colony Count, Microbial; Denture Bases; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Galactose; Glucose; Humans; Indicators and Reagents; Nystatin; Polymethyl Methacrylate; Saliva; Statistics as Topic; Stomatitis, Denture; Sucrose; Tetrazolium Salts; Time Factors | 2001 |
In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens.
Topics: Animals; Antifungal Agents; Candida; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drugs, Chinese Herbal; Female; Fluconazole; Galactose; Humans; Microbial Sensitivity Tests; Saponins; Steroids; Time Factors; Tribulus; Vaginal Diseases | 2005 |
The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Cells, Cultured; Coculture Techniques; Culture Media; Fluconazole; Galactose; Humans; Itraconazole; Mannans; Monocytes | 2007 |
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Galactose; Guideline Adherence; Guidelines as Topic; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Retrospective Studies; Triazoles | 2017 |
Novel Galactopyranoside Esters: Synthesis, Mechanism, In Vitro Antimicrobial Evaluation and Molecular Docking Studies.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; COVID-19; Esters; Fluconazole; Galactose; Humans; Molecular Docking Simulation; SARS-CoV-2 | 2022 |
Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique.
Topics: Alginates; Antifungal Agents; Calorimetry, Differential Scanning; Candida albicans; Cellulose; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Emulsions; Fluconazole; Hexoses; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microspheres; Particle Size; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; X-Ray Diffraction | 2009 |
Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caprylates; Delayed-Action Preparations; Drug Compounding; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Genes, MDR; Hexoses; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nanoparticles; Palmitates; Particle Size; Triglycerides; Verapamil | 2019 |